SG-Logo.png
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
09 août 2022 07h05 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for...
SG-Logo.png
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
04 août 2022 10h16 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its...
SG-Logo.png
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
29 juil. 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will...
SG-Logo.png
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
14 juil. 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...
SG-Logo.png
SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2022  
10 mai 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first...
SG-Logo.png
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
27 avr. 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming...
SG-Logo.png
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
13 avr. 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for...
SG-Logo.png
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
15 mars 2022 07h02 HE | SOPHiA GENETICS, Inc.
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed BOSTON and LAUSANNE, Switzerland, March 15, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a...
SG-Logo.png
SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
04 mars 2022 08h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr....
SG-Logo.png
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
16 févr. 2022 07h00 HE | SOPHiA GENETICS, Inc.
BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the...